Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China ED Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China ED Treatment market. Detailed analysis of key players, along with key growth strategies adopted by ED Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
CSBIO
Seoul Pharma
Teva Pharma
SK Chemicals
Metuchen Pharma
Bayer
BaiYunShan General Factory
Dong-A ST
Pfizer
By Type:
Sildenafil
Tadalafil
Others
By End-User:
Hospitals
Drugstores
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of ED Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China ED Treatment Market Size and Growth Rate of Sildenafil from 2016 to 2027
-
1.3.2 China ED Treatment Market Size and Growth Rate of Tadalafil from 2016 to 2027
-
1.3.3 China ED Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China ED Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China ED Treatment Market Size and Growth Rate of Drugstores from 2016 to 2027
-
1.4.3 China ED Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of ED Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of ED Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Sildenafil
-
3.4.2 Market Size and Growth Rate of Tadalafil
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of ED Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of ED Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of ED Treatment in Hospitals
-
4.4.2 Market Size and Growth Rate of ED Treatment in Drugstores
-
4.4.3 Market Size and Growth Rate of ED Treatment in Other
5 Market Analysis by Regions
-
5.1 China ED Treatment Production Analysis by Regions
-
5.2 China ED Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China ED Treatment Landscape Analysis
-
6.1 North China ED Treatment Landscape Analysis by Major Types
-
6.2 North China ED Treatment Landscape Analysis by Major End-Users
7 Central China ED Treatment Landscape Analysis
-
7.1 Central China ED Treatment Landscape Analysis by Major Types
-
7.2 Central China ED Treatment Landscape Analysis by Major End-Users
8 South China ED Treatment Landscape Analysis
-
8.1 South China ED Treatment Landscape Analysis by Major Types
-
8.2 South China ED Treatment Landscape Analysis by Major End-Users
9 East China ED Treatment Landscape Analysis
-
9.1 East China ED Treatment Landscape Analysis by Major Types
-
9.2 East China ED Treatment Landscape Analysis by Major End-Users
10 Northeast China ED Treatment Landscape Analysis
-
10.1 Northeast China ED Treatment Landscape Analysis by Major Types
-
10.2 Northeast China ED Treatment Landscape Analysis by Major End-Users
11 Southwest China ED Treatment Landscape Analysis
-
11.1 Southwest China ED Treatment Landscape Analysis by Major Types
-
11.2 Southwest China ED Treatment Landscape Analysis by Major End-Users
12 Northwest China ED Treatment Landscape Analysis
-
12.1 Northwest China ED Treatment Landscape Analysis by Major Types
-
12.2 Northwest China ED Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 CSBIO
-
13.1.1 CSBIO Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Seoul Pharma
-
13.2.1 Seoul Pharma Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Teva Pharma
-
13.3.1 Teva Pharma Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 SK Chemicals
-
13.4.1 SK Chemicals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Metuchen Pharma
-
13.5.1 Metuchen Pharma Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Bayer
-
13.6.1 Bayer Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 BaiYunShan General Factory
-
13.7.1 BaiYunShan General Factory Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Dong-A ST
-
13.8.1 Dong-A ST Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Pfizer
-
13.9.1 Pfizer Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China ED Treatment Market Size and Growth Rate of Sildenafil from 2016 to 2027
-
Figure China ED Treatment Market Size and Growth Rate of Tadalafil from 2016 to 2027
-
Figure China ED Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China ED Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China ED Treatment Market Size and Growth Rate of Drugstores from 2016 to 2027
-
Figure China ED Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China ED Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of ED Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of ED Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of ED Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of ED Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Sildenafil
-
Figure Market Size and Growth Rate of Tadalafil
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of ED Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of ED Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Drugstores
-
Figure Market Size and Growth Rate of Other
-
Table China ED Treatment Production by Regions
-
Table China ED Treatment Production Share by Regions
-
Figure China ED Treatment Production Share by Regions in 2016
-
Figure China ED Treatment Production Share by Regions in 2021
-
Figure China ED Treatment Production Share by Regions in 2027
-
Table China ED Treatment Consumption by Regions
-
Table China ED Treatment Consumption Share by Regions
-
Figure China ED Treatment Consumption Share by Regions in 2016
-
Figure China ED Treatment Consumption Share by Regions in 2021
-
Figure China ED Treatment Consumption Share by Regions in 2027
-
Table North China ED Treatment Consumption by Types from 2016 to 2027
-
Table North China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China ED Treatment Consumption Share by Types in 2016
-
Figure North China ED Treatment Consumption Share by Types in 2021
-
Figure North China ED Treatment Consumption Share by Types in 2027
-
Table North China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table North China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China ED Treatment Consumption Share by End-Users in 2016
-
Figure North China ED Treatment Consumption Share by End-Users in 2021
-
Figure North China ED Treatment Consumption Share by End-Users in 2027
-
Table Central China ED Treatment Consumption by Types from 2016 to 2027
-
Table Central China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China ED Treatment Consumption Share by Types in 2016
-
Figure Central China ED Treatment Consumption Share by Types in 2021
-
Figure Central China ED Treatment Consumption Share by Types in 2027
-
Table Central China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China ED Treatment Consumption Share by End-Users in 2016
-
Figure Central China ED Treatment Consumption Share by End-Users in 2021
-
Figure Central China ED Treatment Consumption Share by End-Users in 2027
-
Table South China ED Treatment Consumption by Types from 2016 to 2027
-
Table South China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China ED Treatment Consumption Share by Types in 2016
-
Figure South China ED Treatment Consumption Share by Types in 2021
-
Figure South China ED Treatment Consumption Share by Types in 2027
-
Table South China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table South China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China ED Treatment Consumption Share by End-Users in 2016
-
Figure South China ED Treatment Consumption Share by End-Users in 2021
-
Figure South China ED Treatment Consumption Share by End-Users in 2027
-
Table East China ED Treatment Consumption by Types from 2016 to 2027
-
Table East China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China ED Treatment Consumption Share by Types in 2016
-
Figure East China ED Treatment Consumption Share by Types in 2021
-
Figure East China ED Treatment Consumption Share by Types in 2027
-
Table East China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table East China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China ED Treatment Consumption Share by End-Users in 2016
-
Figure East China ED Treatment Consumption Share by End-Users in 2021
-
Figure East China ED Treatment Consumption Share by End-Users in 2027
-
Table Northeast China ED Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China ED Treatment Consumption Share by Types in 2016
-
Figure Northeast China ED Treatment Consumption Share by Types in 2021
-
Figure Northeast China ED Treatment Consumption Share by Types in 2027
-
Table Northeast China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China ED Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China ED Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China ED Treatment Consumption Share by End-Users in 2027
-
Table Southwest China ED Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China ED Treatment Consumption Share by Types in 2016
-
Figure Southwest China ED Treatment Consumption Share by Types in 2021
-
Figure Southwest China ED Treatment Consumption Share by Types in 2027
-
Table Southwest China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China ED Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China ED Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China ED Treatment Consumption Share by End-Users in 2027
-
Table Northwest China ED Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China ED Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China ED Treatment Consumption Share by Types in 2016
-
Figure Northwest China ED Treatment Consumption Share by Types in 2021
-
Figure Northwest China ED Treatment Consumption Share by Types in 2027
-
Table Northwest China ED Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China ED Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China ED Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China ED Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China ED Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of CSBIO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSBIO
-
Figure Sales and Growth Rate Analysis of CSBIO
-
Figure Revenue and Market Share Analysis of CSBIO
-
Table Product and Service Introduction of CSBIO
-
Table Company Profile and Development Status of Seoul Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seoul Pharma
-
Figure Sales and Growth Rate Analysis of Seoul Pharma
-
Figure Revenue and Market Share Analysis of Seoul Pharma
-
Table Product and Service Introduction of Seoul Pharma
-
Table Company Profile and Development Status of Teva Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharma
-
Figure Sales and Growth Rate Analysis of Teva Pharma
-
Figure Revenue and Market Share Analysis of Teva Pharma
-
Table Product and Service Introduction of Teva Pharma
-
Table Company Profile and Development Status of SK Chemicals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals
-
Figure Sales and Growth Rate Analysis of SK Chemicals
-
Figure Revenue and Market Share Analysis of SK Chemicals
-
Table Product and Service Introduction of SK Chemicals
-
Table Company Profile and Development Status of Metuchen Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metuchen Pharma
-
Figure Sales and Growth Rate Analysis of Metuchen Pharma
-
Figure Revenue and Market Share Analysis of Metuchen Pharma
-
Table Product and Service Introduction of Metuchen Pharma
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of BaiYunShan General Factory
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BaiYunShan General Factory
-
Figure Sales and Growth Rate Analysis of BaiYunShan General Factory
-
Figure Revenue and Market Share Analysis of BaiYunShan General Factory
-
Table Product and Service Introduction of BaiYunShan General Factory
-
Table Company Profile and Development Status of Dong-A ST
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong-A ST
-
Figure Sales and Growth Rate Analysis of Dong-A ST
-
Figure Revenue and Market Share Analysis of Dong-A ST
-
Table Product and Service Introduction of Dong-A ST
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
